Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter 2024 financial results and 2025 financial guidance on Feb. 6, 2025. Lilly will also conduct a conference call that day with the ...

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh® (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn ...

Along with serving cocktails and pizza, The Last Refuge serves as a brand center for Heaven's Door Spirits, which was ...

It was a wild week in Paris. From shimmery polychromatic printed velvets to lustrous capiz shell wallcoverings, here are some ...

Earnings Report 5.302 USD Q4 2024 Earnings Release 02/06/2025 Earnings Report 4.954 USD Q1 2025 Earnings Release 05/01/2025 Earnings Report 5.770 USD Q2 2025 Earnings Release 08/07/2025 Earnings ...

Get the poll delivered straight to your inbox with AP Top 25 Poll Alerts. Sign up here. Brown Bears (8-7, 0-2 Ivy League) at Cornell Big Red (10-5, 2-0 Ivy League) Ithaca, New York; Monday, 2 p.m. EST ...

Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December scripts boost. The stock is attractively valued at current levels.